Nebraska Hematology and Oncology is a clinical research site located in Lincoln, Nebraska, United States 68506.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Nebraska Hematology and Oncology has participated in 55 clinical trials with 28 currently active.
Therapeutic areas: Plasma Cell Myeloma, Malignant Neoplasm, Adenocarcinoma of the Prostate.
Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.
Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nebraska Hematology and Oncology has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nebraska Hematology and Oncology has 55 clinical trials on record, with 28 currently active. Their work covers Plasma Cell Myeloma, Malignant Neoplasm, Adenocarcinoma of the Prostate.
Nebraska Hematology and Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.